52 results on '"De Deyn, Peter Paul"'
Search Results
2. The Association Between Biomarkers and Neuropsychiatric Symptoms Across the Alzheimer's Disease Spectrum
3. Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia
4. Investigation of the role of matrix metalloproteinases in the genetic etiology of Alzheimer's disease
5. Senescent Changes in Cerebrospinal Fluid Circulatory Physiology and Their Role in the Pathogenesis of Normal-tension Glaucoma
6. Quality of Life after Ischemic Stroke Varies in Western Countries: Data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST)
7. GIGYF2 has no major role in Parkinson genetic etiology in a Belgian population
8. Added diagnostic value of CSF biomarkers in differential dementia diagnosis
9. Cortical sources of resting EEG rhythms in mild cognitive impairment and subjective memory complaint
10. Serum N-glycan profile shift during human ageing
11. Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia
12. Intraneuronal amyloid β and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease
13. Accumulation of methylguanidine and changes in guanidino compound levels in plasma, urine, and kidneys of furosemide-treated rats
14. Early Recovery and Functional Outcome are Related with Causal Stroke Subtype: Data from the Tinzaparin in Acute Ischemic Stroke Trial
15. Complex Compartmental Behavior of Small Water-Soluble Uremic Retention Solutes: Evaluation by Direct Measurements in Plasma and Erythrocytes
16. Effect of Morris water maze diameter on visual-spatial learning in different mouse strains
17. Factor Analysis of the Cohen-Mansfield Agitation Inventory in Three Large Samples of Nursing Home Patients With Dementia and Behavioral Disturbance
18. In vitro study of the potential role of guanidines in leukocyte functions related to atherogenesis and infection
19. Contribution of VPS35 genetic variability to LBD in the Flanders-Belgian population
20. Review on uremic toxins: Classification, concentration, and interindividual variability
21. DLB and PDD: a role for mutations in dementia and Parkinson disease genes?
22. THE ASSOCIATION BETWEEN AFFECTIVE SYMPTOMS AND ALZHEIMER’S DISEASE BIOMARKERS ACROSS THE DISEASE SPECTRUM
23. IMPROVED DIAGNOSTIC ACCURACY USING THE CEREBROSPINAL FLUID AMYLOID BETA 1-42/1-40 RATIO
24. INVESTIGATING THE INVOLVEMENT OF THE DPP6-KV4.2 PROTEIN COMPLEX IN DEMENTIA
25. Alzheimer's disease and glaucoma: Look-alike neurodegenerative diseases
26. NEUROGRANIN IN CEREBROSPINAL FLUID IS NOT SPECIFIC TO ALZHEIMER’S DISEASE DEMENTIA
27. IN-DEPTH ANALYSIS OF AN ABCA7 VNTR IN ALZHEIMER’S DISEASE
28. THE ASSOCIATION BETWEEN APATHY AND STRUCTURAL BRAIN ALTERATIONS IN AMNESTIC MILD COGNITIVE IMPAIRMENT
29. EXPLORING THE MOLECULAR MECHANISM OF NEURONAL HYPEREXCITABILITY IN DEMENTIA
30. PRE-ANALYTICAL STABILITY OF NOVEL CEREBROSPINAL FLUID BIOMARKERS FOR DEMENTIA
31. BIOLOGICAL FLUID MONOAMINE LEVELS TO EXPLORE THE NEUROCHEMICAL CONTINUUM BETWEEN FRONTOTEMPORAL DEMENTIA AND AMYOTROPHIC LATERAL SCLEROSIS
32. MONOAMINERGIC CORRELATES OF DISINHIBITED BEHAVIOURS IN THE NOVEL TAU58/4 TRANSGENIC MOUSE MODEL FOR TAUOPATHY
33. CONTRIBUTION OF RARE DELETERIOUS ABCA7 MUTATIONS TO A BELGIAN EARLY-ONSET ALZHEIMER’S DISEASE COHORT
34. EPISODIC MEMORY IN MILD COGNITIVE IMPAIRMENT INVERSELY CORRELATES WITH THE PATIENT CONTRIBUTION TO CEREBRAL BLOOD FLOW NETWORK MODULARITY
35. TRANSCRIPTOME ANALYSIS IN BLOOD AND BRAIN IDENTIFIES GENE EXPRESSION REGULATION AND CORRESPONDING QUANTITATIVE TRAIT LOCI IN ALZHEIMER’S DISEASE
36. CSF BIOMARKERS TO PREDICT RATE OF COGNITIVE DECLINE IN ALZHEIMER’S DISEASE
37. PSP and small vessel disease: more than occasional co-occurence?
38. HIGH SCORES ON A 22-GENE RISK SCORE FOR ALZHEIMER'S DEMENTIA CORRELATE WITH EARLIER ONSET AGE AND REDUCED CSF Aβ
39. A way with metaphors: An analysis of literary work produced in early MCI due to Alzheimer's disease
40. Are depressive symptoms in mild cognitive impairment patients predictive for conversion to dementia?
41. Characterisation of Depression in Dementia and Mild Cognitive Impairment
42. Predicting conversion to Alzheimer's disease in Mild Cognitive Impairment: cued recall versus free delayed recall
43. P3-206: Genetic variability at the progranulin locus contributes to risk for Alzheimer's disease
44. P3-159: MAPT H1 subhaplotyping in european PD association samples implicates tau splicing in early-onset parkinson’s disease susceptibility
45. P1-321: Contribution of dementia genes to Alzheimer’s disease in Belgium
46. P3-037 CSF dopac levels predict aggressive and agitated behavior in FTD patients
47. P4-086 5-HT 2A receptor polymorphism may modulate antipsychotic treatment response in Alzheimer's disease
48. P4-033 Dose dependent effect of APOE ε4 on behavioral symptoms in frontal lobe dementia patients
49. P3-352 The middelheim frontality score: a behavioral assessment scale that discriminates frontotemporal dementia from Alzheimer's disease
50. P1-310 Symptoms profile of dementia-patients displaying aggressive, agitated and psychological behaviors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.